Researchers Mapped METTL14 Regulatory Mechanism
A newly identified cell-cycle pathway links RLIM and METTL14 to modulate RNA modification processes.
Updated on Oct. 6, 2026 in Life Sciences
Researchers have identified a cell-cycle-dependent ubiquitination mechanism of METTL14 that regulates mRNA mA levels. The study demonstrates that this process, which maintains epitranscriptomic quality control, is clinically relevant in acute monocytic leukemia.
Why it matters
This research reveals how cells ensure the fidelity of mRNA modification during the cell cycle by modulating the METTL3-METTL14 complex. Understanding this pathway provides insight into how epitranscriptomic regulation influences disease states like acute monocytic leukemia.
The study identified K27-linked ubiquitination as a key modulator of METTL3-METTL14 complex assembly. Unlike typical degradation pathways, this process modulates RNA substrate engagement independently of overall protein stability.
The players
METTL14
A methyltransferase enzyme that forms part of the METTL3-METTL14 complex responsible for RNA methylation.
RLIM
A ubiquitin ligase protein that serves as a regulatory target for cell-cycle-dependent phosphorylation.
CDK1/cyclin B1
A kinase complex that acts as a master regulator of the cell cycle by phosphorylating key proteins.
The details
The regulatory cascade initiates when the protein complex CDK1/cyclin B1 phosphorylates the protein RLIM. This phosphorylation triggers the self-ubiquitination and subsequent proteasomal degradation—the cellular machinery for recycling unneeded proteins—of RLIM. This event regulates the deposition of K27-linked ubiquitin on METTL14, which directly influences the assembly and mRNA substrate engagement of the METTL3-METTL14 complex.
Timeline
- 2026-10-06
Publication of the research findings.
The Tech Race
This study extends the current understanding of the epitranscriptomics research field by defining a specific quality-control mechanism for RNA modification. It clarifies how cellular machinery coordinates RNA methylation with the broader cell cycle.
This research defines a molecular pathway relevant to acute monocytic leukemia, though clinical applications remain in the research stage. Scientists and clinical researchers should monitor this pathway for potential targets in future therapeutic development.
The takeaway
The research highlights that RNA modification is not a static process but a cycle-dependent event tightly governed by protein phosphorylation. Observers should track subsequent studies for potential pharmacological inhibitors targeting the RLIM-METTL14 interaction in leukemia models.
Further reading
For broader context on cellular regulation, see recent developments in Life Sciences.
More information
Read the full results in the Nature Chemical Biology research article.
Source note: This article includes information reported by Nature.
